In SS, it has been shown that IFN-γ is an early regulator of the acinar cell pathology by inhibiting the G1 phase of the acinar cell cycle, altering integrin expression and decreasing cell viability [5]. This evidence concerns the gene IFNG and synovial sarcoma.